IRIS
GRIGIONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.238
NA - Nord America 7.112
EU - Europa 3.108
SA - Sud America 1.001
Continente sconosciuto - Info sul continente non disponibili 199
AF - Africa 133
OC - Oceania 77
Totale 24.868
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 8.903
US - Stati Uniti d'America 6.851
CN - Cina 1.831
IT - Italia 1.516
HK - Hong Kong 1.097
BR - Brasile 716
VN - Vietnam 450
GB - Regno Unito 386
BD - Bangladesh 377
FR - Francia 337
DE - Germania 251
IN - India 156
NL - Olanda 155
CA - Canada 129
AR - Argentina 101
ID - Indonesia 90
AU - Australia 76
EE - Estonia 74
MX - Messico 69
CZ - Repubblica Ceca 54
EC - Ecuador 52
ZA - Sudafrica 49
FI - Finlandia 48
TR - Turchia 47
CO - Colombia 44
RU - Federazione Russa 40
JP - Giappone 38
UA - Ucraina 36
ES - Italia 31
PH - Filippine 31
IQ - Iraq 28
PK - Pakistan 27
CL - Cile 24
PL - Polonia 24
SA - Arabia Saudita 24
MY - Malesia 23
IR - Iran 21
MA - Marocco 20
PY - Paraguay 19
VE - Venezuela 19
BE - Belgio 15
JM - Giamaica 15
MD - Moldavia 15
TN - Tunisia 15
SE - Svezia 14
AL - Albania 12
AT - Austria 12
LT - Lituania 12
RO - Romania 12
TH - Thailandia 11
PE - Perù 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
CH - Svizzera 9
GR - Grecia 9
UZ - Uzbekistan 9
DO - Repubblica Dominicana 8
DZ - Algeria 8
JO - Giordania 8
EG - Egitto 7
HN - Honduras 7
CR - Costa Rica 6
IL - Israele 6
KE - Kenya 6
NP - Nepal 6
UY - Uruguay 6
GE - Georgia 5
GT - Guatemala 5
HU - Ungheria 5
NI - Nicaragua 5
NO - Norvegia 5
PT - Portogallo 5
SV - El Salvador 5
TW - Taiwan 5
IE - Irlanda 4
KZ - Kazakistan 4
MK - Macedonia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
ET - Etiopia 3
GA - Gabon 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
OM - Oman 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
CG - Congo 2
CM - Camerun 2
CY - Cipro 2
DK - Danimarca 2
KG - Kirghizistan 2
KR - Corea 2
LU - Lussemburgo 2
PR - Porto Rico 2
Totale 24.633
Salva come PNG Salva come JPEG
Città #
San Jose 1.803
Ashburn 1.483
Singapore 1.260
Hong Kong 1.081
Rome 853
Hefei 615
Council Bluffs 475
Dallas 418
Boardman 370
Columbus 350
Beijing 345
Lauterbourg 281
London 277
Shanghai 210
Ho Chi Minh City 150
Phoenix 124
Santa Clara 122
Amsterdam 109
Hanoi 108
Los Angeles 104
New York 98
Munich 75
Milan 71
Tallinn 69
São Paulo 61
San Francisco 47
Mexico City 45
Washington 45
Seattle 42
Frankfurt am Main 41
Brno 39
Buffalo 34
Pune 33
Tokyo 31
Toronto 30
Chicago 29
Helsinki 29
Las Vegas 29
Montreal 29
Rio de Janeiro 27
Brooklyn 26
West Jordan 26
Chennai 23
Melbourne 23
Orem 23
Perth 22
Atlanta 21
Naples 20
Boston 19
Turin 19
Warsaw 19
Johannesburg 18
Turku 18
Bologna 17
Brasília 17
Guayaquil 17
Jinan 17
Qingdao 17
Santiago 16
Da Nang 15
Manchester 15
Nuremberg 15
Philadelphia 15
Quito 15
Jakarta 14
Palermo 14
Porto Alegre 14
Xi'an 14
Bari 13
Haiphong 13
Hangzhou 13
Reggio Emilia 13
Salvador 13
Shenzhen 13
Sydney 13
Thái Bình 13
Belo Horizonte 11
Bengaluru 11
Biên Hòa 11
Dhaka 11
Hanover 11
Bắc Ninh 10
Delhi 10
Florence 10
Hải Dương 10
Kuala Lumpur 10
Miami 10
Olomouc 10
Oxford 10
Staten Island 10
Stockholm 10
Zhengzhou 10
Ankara 9
Bogotá 9
Buenos Aires 9
Campinas 9
Can Tho 9
Changsha 9
Charlotte 9
Denver 9
Totale 12.292
Salva come PNG Salva come JPEG
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 451
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 278
Current management and prognosis of patients with recurrent myocardial infarction 253
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 248
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 248
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 246
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence 246
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 242
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 239
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 238
Assessment of cardiopulmonary capacity in deconditioned athletes because of knee injury 236
Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? 236
An open international registry to evaluate medical and surgical outcomes of aortic valve insufficiency and ascending aorta aneurysm. 231
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 229
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 229
Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention 228
Simultaneous presence of Brugada and overgrowth syndromes 228
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 226
A sudden right-to-left shunt: the importance of evaluating patent foramen ovale during exercise 226
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 223
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 221
Platelet reactivity and clinical outcomes following percutaneous coronary intervention in complex higher-risk patients 221
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 220
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 217
Acute pharmacological tests in patients with primary and precapillary secondary pulmonary hypertension 216
Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. 213
Age and heart transplantation: results from a heart failure management unit. 213
Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma 212
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 212
Cardiovascular and metabolic effects of hyperbilirubinemia in a cohort of Italian Olympic athletes 210
Andamento dei livelli plasmatici dei neurormoni dopo il trapianto cardiaco 204
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 196
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 183
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 160
A State-of-the-Art Review on Sleep Apnea Syndrome and Heart Failure 154
A novel tricuspid flow optimiser for severe tricuspid regurgitation (TRiFlO) 154
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 153
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 151
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 148
Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years 144
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 137
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 135
The MIDA-Q Mortality Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum 135
Impact of endothelial dysfunction on long-term clinical outcomes in patients with chronic coronary syndromes treated with second generation drug-eluting stent implantation 133
Non-INvasive Functional and Anatomic vascular evaluation for the prediction of coronary artery disease: The NINFA study 133
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus 132
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 130
Breath Analysis via Gas Chromatography-Mass Spectrometry (GC-MS) in Chronic Coronary Syndrome (CCS): A Proof-of-Concept Study 128
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 126
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 126
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 123
Acute heart failure in patients with acute aortic syndrome: Pathophysiology and clinical-prognostic implications 122
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 121
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 118
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 117
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study 117
Aortic Valve Surgery in Nonelderly Patients: Insights Gained From AVIATOR 117
Invasive Assessment of Coronary Microvascular Function 113
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 112
Assessment of mitral regurgitation through Doppler echocardiography: Feasibility, pitfalls and diagnostic advantages 109
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 104
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 103
Systematic review and meta-analysis of randomized and nonrandomized studies on fractional flow reserve-guided revascularization 103
Athlete's ECG Made Easy: A Practical Guide to Surviving Everyday Clinical Practice 101
Tricuspid regurgitation: what is the real clinical impact and how often should it be treated? 101
Chemoreceptor hyperactivity in heart failure: Is lactate the culprit? 100
Disproportionate Left Ventricular Enlargement in Mitral Valve Prolapse: Prevalence, Predictors, and Association With Outcomes 97
Length and Type of Antibiotic Prophylaxis for Infection Prevention in Adults Patient in the Cardiac Surgery Intensive Care Unit: A Narrative Review 93
The current paradigm of cardiac troponin increase among athletes 91
Practical Guidance for the Use of SGLT2 Inhibitors in Heart Failure 89
Relation of endothelin-1 to survival in patients with primary pulmonary hypertension 89
Edge-to-edge repair for tricuspid regurgitation: 1-year follow-up and clinical implications from the TR-Interventional Study 85
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments 83
Valutazione italiana del "Minnesota Living with Heart Failure Questionnaire" 82
Relazione comparativa tra capacità funzionale e profilo emodinamico in pazienti con scompenso cardiaco cronico biventricolare o scompenso cardiaco destro puro 82
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 81
Eosinophilic Myocarditis: From Bench to Bedside 81
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19: a systematic review and meta-analysis 80
Cardiac involvement of Gorlin-Goltz syndrome: new light among the shadows of an old congenital disorder 80
Indexing left ventricular end-systolic dimension to body size: Association with mortality in patients with degenerative mitral regurgitation 77
Traditional and Advanced Echocardiographic Evaluation in Chronic Obstructive Pulmonary Disease: The Forgotten Relation 76
The safety of transesophageal echocardiography to guide transcatheter tricuspid valve edge-to-edge repair 76
Extracorporeal Membrane Oxygenation Support in Refractory Cardiogenic Shock: Treatment Strategies and Analysis of Risk Factors 76
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study 75
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 73
Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry 71
Platelet function and markers of atherothrombotic risk in individuals with parathyroid disorders 70
The Central Role of Left Atrium in Heart Failure 69
Impact of Chronic Kidney Disease and Platelet Reactivity on Clinical Outcomes Following Percutaneous Coronary Intervention 68
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 68
Evaluation of postural disorders in patients pre and post heart transplant. 68
Evaluation of Cardiac Autonomic Function in Patients Undergoing Thoracoscopic Sympathetic Chain Clamping for Primary Focal Hyperhidrosis 67
Histological and histometric characterization of myocardial fibrosis in end-stage hypertrophic cardiomyopathy. A Clinical-Pathological Study of 30 Explanted Hearts 66
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions 65
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 65
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 64
Prognostic implications of functional tricuspid regurgitation in asymptomatic degenerative mitral regurgitation 64
Management of asymptomatic mitral regurgitation. 63
Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures 62
Role of polypill in cardiovascular prevention and treatment 62
Totale 14.437
Salva come PNG Salva come JPEG
Categoria #
all - tutte 150.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 150.127
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022329 0 0 7 11 6 9 6 3 15 16 13 243
2022/2023283 10 9 22 18 29 4 10 11 6 7 153 4
2023/20241.461 24 115 82 90 109 459 58 304 64 72 24 60
2024/202510.194 211 100 368 177 83 286 192 61 760 713 3.500 3.743
2025/202610.963 822 376 849 1.295 435 674 2.595 931 901 963 654 468
2026/20271.636 279 993 364 0 0 0 0 0 0 0 0 0
Totale 24.868